SVM Medscape Education Collaborative

These activities were developed through a collaboration between Society for Vascular Medicine and Medscape Education. Supported by an independent educational grant from Janssen Pharmaceuticals, Inc.

0.25 CME / ABIM MOC / CE

Peripheral Artery Disease and Dual Antithrombotic Strategies: What Do the Latest Data Suggest?

What do you know about dual-pathway inhibition in patients with peripheral artery disease (PAD) undergoing lower-extremity revascularization? The experts discuss.

Authors: Geoffrey D. Barnes, MD, MSc; Marc Bonaca, MD, MPH

Authors: Geoffrey D. Barnes, MD, MSc; Marc Bonaca, MD, MPH
CME / ABIM MOC / CE Released: 7/7/2022
Valid for credit through: 7/7/2023

0.50 CME / ABIM MOC / CE

Calling All Vascular Specialists! Interprofessional Approaches to Improve Peripheral Artery Disease Management Today

How can your vascular team improve the management of patients with peripheral artery disease (PAD)? An interprofessional team discusses.

Authors: Esther S.H. Kim, MD, MPH; Debra Kohlman-Trigoboff, ACNP-BC, CVN; Jennifer Anne Rymer, MD

Authors: Esther S.H. Kim, MD, MPH; Debra Kohlman-Trigoboff, ACNP-BC, CVN; Jennifer Anne Rymer, MD
CME / ABIM MOC / CE Released: 7/25/2022
Valid for credit through: 7/25/2023

0.25 CME / ABIM MOC / CE

Peripheral Artery Disease Quickfire Case Challenges: Where Does Antithrombotic Therapy for Vascular Protection Fit?

How do you optimize antithrombotic therapy following revascularization? Drs Kolluri and Li discuss.

Authors: Raghu Kolluri, MD, MS, RVT, FSVM; Jun Li, MD, FACC, FSCAI

Authors: Raghu Kolluri, MD, MS, RVT, FSVM; Jun Li, MD, FACC, FSCAI
CME / ABIM MOC / CE Released: 8/25/2022
Valid for credit through: 8/25/2023

0.25 CME / ABIM MOC / CE

Evolving Strategies in Peripheral Artery Disease Post-Revascularization: Insights for the Vascular Team

What is the most appropriate antithrombotic strategy post-revascularization? Drs Bonaca and Kadian-Dodov discuss.

Authors: Marc Bonaca, MD, MPH; Daniella Kadian-Dodov, MD

Authors: Marc Bonaca, MD, MPH; Daniella Kadian-Dodov, MD
CME / ABIM MOC / CE Released: 8/24/2022
Valid for credit through: 8/24/2023

0.50 CME / ABIM MOC / CE

What Vascular Specialists Need to Know About Antithrombotic Strategies in Peripheral Artery Disease Post-Revascularization

What is the most appropriate antithrombotic strategy after lower-extremity revascularization? Drs Aronow, Secemsky, and Washam discuss.

Authors: Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; Jeffrey B. Washam, PharmD, FAHA

Authors: Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; Jeffrey B. Washam, PharmD, FAHA
CME / ABIM MOC / CE Released: 8/25/2022
Valid for credit through: 8/25/2023

0.75 CME

Treating Peripheral Artery Disease in the Modern World: Vascular Insights Into the Role of Dual Pathway Inhibition

Are your patients with peripheral artery disease (PAD) on dual pathway inhibition? Listen as our experts discuss the latest data on this new treatment strategy.

Authors: Herbert D. Aronow, MD, MPH; Daniella Kadian-Dodov, MD; Esther S.H. Kim, MD, MPH, FSVM; Melissa Strickengloss, MSN, NP-C

0.25 CME / ABIM MOC

Identifying Patients With Peripheral Artery Disease: A Call to Action to Assess and Screen the Right Patients

Would you like to know more about assessing and screening the right patients for peripheral artery disease?

Authors: Soo Hyun (Esther) Kim, MD, MPH; Charles P. Vega, MD

0.25 CME / ABIM MOC

Approaches to the Ankle-Brachial Index for Diagnosing Peripheral Artery Disease: From Testing to Interpretation

Want to know when and how to use the ankle-brachial index (ABI) to identify patients with peripheral artery disease (PAD)?

Authors: Soo Hyun (Esther) Kim, MD, MPH; Charles P. Vega, MD

0.25 CME / ABIM MOC

Managing Peripheral Artery Disease Post-Revascularization: Translating New Data Into Practice

Improve outcomes in post-revascularization patients with peripheral artery disease (PAD). Integrate the latest data for using dual antithrombotic therapy.

Authors: Joshua Beckman, MD; Charles P. Vega, MD

Authors: Joshua Beckman, MD; Charles P. Vega, MD
CME / ABIM MOC Released: 12/12/2022
Valid for credit through: 12/12/2023

2021 SVM and Medscape Education Activities

→ Click Here to access the below activities

Diagnosing PAD in Clinical Practice: From A to E
0.25 CME
Get expert guidance from Drs. Aronow, Kim, and Patel on patient assessment for PAD.

The Latest in PAD: An Update for Practicing Vascular Specialists
.25 CME / ABIM MOC
Drs Patel and Kolluri discuss antithrombotic therapy in PAD patients undergoing revascularization.

Caring for Patients With Vascular Disease: A Virtual Patient
1.0 CME / CE / ABIM MOC
Review the diagnosis and treatment of PAD.

DOACS and Dual Pathway Inhibition: The Relationship Between Arterial and Venous Thrombotic Events
0.25 CME / ABIM MOC
In the final episode of the series, Dr. Bhatt discusses the interplay of arterial and venous thromboembolic events and management strategies.

Patients With PAD and CAD: Collaborative Care Approaches To Improve Outcomes
0.25 CME / ABIM MOC
Dr. Deepak Bhatt review the importance of identifying the polyvascular patient.

Managing PAD To Prevent Limb Loss: The Role of Antithrombotic Therapy
Dr. Schuyler Jones review optimal treatment strategies to manage PAD.

Managing PAD Across the Disease Spectrum: Latest Data and Implications for Patient Care
In the first episode of PAD TV, Dr Schuyler Jones discusses the latest advances in the diagnosis and treatment of PAD.

Treating PAD After Revascularization: What, How, and When?
Drs. Bonaca and Aronow discuss antithrombotic therapy in PAD Patients undergoing revascularization.